Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent

International Journal of Antimicrobial Agents

Volumn 12, Issue 3, 1999, Pages 213-219

  Manavathu, Elias K ^a   Vazquez, Jose A ^a   Chandrasekar, Pranatharthi H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antifungal agents; Aspergillus fumigatus; Drug resistance; Itraconazole; Resistant mutants

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG SENSITIVITY; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, MICROBIAL; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 0032769784     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00102-2     Document Type: Article

References (14)

1. Manavathu EK, Alangaden GJ, Lerner SA. Isolation and characterization of itraconazole-resistant mutants of Aspergillus fumigatus. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1995: American Society for Microbiology, Washington DC, USA, Abstract C, p. 570.
2. White A, Goetz MB. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994;19:687-92.
3. White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α-demethylase in Candida albicans. Antimicrob Agents Chemother 1997;41:1488-94.
4. White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997;41:1482-7.
5. Sanglard D, Ischer F, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995;39:2378-86.
6. Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996;40:2300-5.
7. Sanglard D, Majcherczyk P, Ischer F, Bille J. A rapid colorometric method for the study of resistance mechanism to azole antifungal agents on yeasts. Clin Microbiol Infect 1997;3(Suppl 2):83.
8. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41:1364-8.
9. Oakley KL, Morrissey G, Denning DW. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41:1504-7.
10. Manavathu EK, Cutright JL, Chandrasekar PH. In vitro susceptibility of itraconazole-resistant isolates of Aspergillus fumigatus to voriconazole. Clin Microbiol Infect 1997;3(suppl 2):81.
11. Abraham OC, Manavathu EK, Chandrasekar PH. In vitro activities of voriconazole, itraconazole and amphotericin B against Aspergillus species. Abstracts of the 35th Annual Meeting of Infectious Diseases Society of America. Clin Infect Dis 1997;25:378.
12. Manavathu EK, Alangaden G J, Lerner SA. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Can J Microbiol 1996;42:960-4.
13. Espinel-Ingroff A, Dawson K, Pfaller M, et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995;39:314-9.
14. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998;11:382-402.